← Back to headlines
AI-Developed Lung Drug Shows Promise in Reversing Aging Markers
Researchers have reported that a novel lung medication discovered through artificial intelligence successfully reversed key biological aging markers in clinical studies. The findings highlight the growing potential of AI-driven drug discovery in developing targeted anti-aging therapies.
8 Sept, 03:46 — 8 Sept, 09:43
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (46/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left2
Left (2)
newsbeastjapan-times
Center1
Center (1)
bloomberg
Right
Far R
Geographic diversity— 3 regions13/34
Greece1Japan1US1
Sources
Showing 2 of 3 sources
bloombergHigh17h ago
Insilico's Lung Drug Reverses Aging Markers in Study
Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses the implications after an AI-discovered lung drug developed by his company showed promise in reversing biological signs of aging. (Source: Bloomberg)
Read full article →japan-timesMostly Factual11h ago
AI-discovered lung drug reverses aging markers in study
An experimental lung disease drug developed using artificial intelligence showed promise in reversing biological signs of aging, pointing to broader potential use of the treatment, according to its developer.
Read full article →Coverage Timeline
First report: bloomberg · 8 Sept, 03:46|Full coverage: 3 · 17h|Window: 17h
Left-leaningCenterRight-leaning
